ASLAN Pharmaceuticals

Investor Relations

SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group View
6-K/A

Amendment to a previously filed 6-K
Current Reports
 View HTML
0001564590-20-053711.pdf
0001564590-20-053711.rtf
0001564590-20-053711.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-052245.pdf
0001564590-20-052245.rtf
0001564590-20-052245.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001193125-20-267200.pdf
0001193125-20-267200.rtf
0001193125-20-267200.xls
EX-101.INS - XBRL INSTANCE DOCUMENT
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Registration Statements
 View HTML
0001193125-20-267301.pdf
0001193125-20-267301.rtf
0001193125-20-267301.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-044147.pdf
0001564590-20-044147.rtf
0001564590-20-044147.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-043862.pdf
0001564590-20-043862.rtf
0001564590-20-043862.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-042589.pdf
0001564590-20-042589.rtf
0001564590-20-042589.xls
F-6EF

F-6EF
Other
 View HTML
0001193805-20-001115.pdf
0001193805-20-001115.rtf
0001193805-20-001115.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-040998.pdf
0001564590-20-040998.rtf
0001564590-20-040998.xls
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Current Reports
 View HTML
0001564590-20-035281.pdf
0001564590-20-035281.rtf
0001564590-20-035281.xls